Joseph M. Unger

2 weeks ago | ascopubs.org | Joseph M. Unger |Hillary Andrews |Laura A. Levit

1-3 Given the challenges of recruiting patients to clinical trials during a pandemic, major federal agencies shared guidance to allow more flexibility in trial processes, supporting the continuity of clinical trials while ensuring patient safety and data integrity.4,5 Trial sponsors rapidly adopted these measures, including strategies such as remote patient consent to participate, remote symptom monitoring, and distribution of oral anticancer agents directly to trial patients.4-6 Enrollment...

May 3, 2024 | healio.com | Josh Friedman |Mindy Valcarcel |Joseph M. Unger

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Participation in cancer treatment trials has more than doubled over the past 30 years. Patients also contribute to other trials, including biorepository, registry, genetic and quality of life.

Oct 13, 2023 | healio.com | Jennifer Southall |Mindy Valcarcel |Joseph M. Unger

You've successfully added Hematology Oncology: Practice Management to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Medicaid expansion led to an annual increase in cancer clinical trial participation.

Oct 11, 2023 | nature.com | Hong Xiao |Joseph M. Unger

AbstractIn April 2022, an outbreak of the SARS-CoV-2 virus Omicron variant in Shanghai precipitated an extensive lockdown. We assessed changes in healthcare utilization during this outbreak and investigated the relationship between the stringency of mitigation strategies and disruptions in healthcare utilization.

Oct 3, 2023 | jdsupra.com | Joseph M. Unger

Effective January 1, 2024, most legal entities incorporated, organized, or registered to do business (i.e., LLCs, LLP, PLLC, Inc., Co., etc.) in a state must disclose information relating to its owners, officers, and controlling persons with the Financial Crimes Enforcement Network, a bureau of the U.S. Department of the Treasury, pursuant to the Corporate Transparency Act (“CTA”).